BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1536717)

  • 1. Natural killer cell function and malignant cell phenotype in hairy cell leukaemia.
    Ogmundsdóttir HM; Thorsteinsson L; Sigfússon A; Sveinsdóttir S; Björnsson S; Eyjólfsson G; Jóhannesson GM; Jensson O
    APMIS; 1992 Jan; 100(1):10-20. PubMed ID: 1536717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
    Nielsen B; Hokland P; Ellegaard J; Hasselbalch H; Hokland M
    Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2.
    Reiter Z; Ozes ON; Blatt LM; Taylor MW
    J Immunother (1991); 1992 Jan; 11(1):40-9. PubMed ID: 1734947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.
    Liberati AM; De Angelis V; Fizzotti M; Schippa M; Cecchini M; Adiuto D; Di Clemente F; Palmisano L; Micozzi E; Zuccaccia M
    Cancer Immunol Immunother; 1994 May; 38(5):323-31. PubMed ID: 7512888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
    Griffiths SD; Cawley JC
    Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C.
    Appasamy R; Bryant J; Hassanein T; Van Thiel DH; Whiteside TL
    Clin Immunol Immunopathol; 1994 Dec; 73(3):350-7. PubMed ID: 7955564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytes from patients with hairy cell leukaemia enable the distinction of two separate subpopulations of activated lymphocyte killer cells generated in mixed lymphocyte culture.
    Werkmeister JA; Boyd AW; Triglia T; Burns GF
    Clin Exp Immunol; 1985 Jul; 61(1):103-8. PubMed ID: 2931219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
    Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
    Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
    Lahat N; Aghai E; Merchav S; Kinarty A; Sobel E; Froom P
    Scand J Immunol; 1990 Aug; 32(2):205-9. PubMed ID: 2389114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
    Reiter Z; Tomson S; Ozes ON; Taylor MW
    Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
    Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
    Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
    Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia.
    Foa R; Lauria F; Lusso P; Raspadori D; Fierro MT; Tazzari PL; Caudana L; Matera L
    Clin Exp Immunol; 1986 May; 64(2):392-8. PubMed ID: 3742880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity.
    Smith BR; Rosenthal DS; Ault KA
    Exp Hematol; 1985 Mar; 13(3):189-93. PubMed ID: 3884356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hairy cell leukaemia: observations on natural killer activity in different clinical stages of the disease.
    Demeter J; Pálóczi K; Lehoczky D; Benczúr M
    Br J Haematol; 1989 Feb; 71(2):239-44. PubMed ID: 2923810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant effect of interferon on natural killer activity and tumor cell sensitivity to lysis in hairy cell leukemia.
    Lahat N; Aghai E; Kotler A; Kinarty A; Sobel E; Gruener N; Froom P
    Blood; 1988 Apr; 71(4):1141-3. PubMed ID: 3258536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune defects in families and patients with xeroderma pigmentosum and trichothiodystrophy.
    Mariani E; Facchini A; Honorati MC; Lalli E; Berardesca E; Ghetti P; Marinoni S; Nuzzo F; Astaldi Ricotti GC; Stefanini M
    Clin Exp Immunol; 1992 Jun; 88(3):376-82. PubMed ID: 1535035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
    Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
    Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-induced enhancement of the susceptibility of hairy cell leukaemia lymphocytes to natural killer cell lysis.
    Cordingley FT; Hoffbrand AV; Brenner MK
    Br J Haematol; 1988 Sep; 70(1):37-41. PubMed ID: 3140887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of maximal exercise on natural killer (NK) cell cytotoxicity and responsiveness to interferon-alpha in the young and old.
    Woods JA; Evans JK; Wolters BW; Ceddia MA; McAuley E
    J Gerontol A Biol Sci Med Sci; 1998 Nov; 53(6):B430-7. PubMed ID: 9823739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.